Testing blood-thinner treatment for clogged aortic bioprosthetic valves
Treatments studied
Part of Heart & circulation clinical trials.
This study checks whether a blood-thinning medicine can treat problems with a bioprosthetic (man-made tissue) aortic valve. It focuses on valve “clots” that can happen after either a catheter-based or surgery-based valve replacement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an aortic bioprosthetic valve placed at least 48 hours ago
- You are age 18 or older
- You can give informed consent and agree to follow study visits and instructions
- Your kidney function is not severely reduced (creatinine must be 1.5 mg/dL or less)
- You do not have a known allergy to iodine/iodinated contrast dye
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether an oral blood thinner (apixaban) works for people who recently received a bioprosthetic aortic valve. It aims to prevent dangerous blood clots while checking safety, especially bleeding risk.
This trial compares aspirin to warfarin in the first six months after receiving a bioprosthetic (tissue) heart valve. It aims to find which treatment better prevents blood clots without causing excessive bleeding.
This study compares a blood thinner pill (a factor Xa inhibitor) with warfarin (vitamin K antagonist) in people who have had a mechanical aortic valve replacement. It looks at which option works better and is safer over the long term.
This trial tests different blood-thinning medicines after a mitral valve repair procedure (TEER) in people who do not need long-term blood thinners. It aims to find the safest and most effective strategy to prevent blood clots.
This Phase 3 study tests whether aiming for a lower blood-thinning test result (INR) can reduce bleeding risk in people with a specific type of mechanical heart valve. The trial checks if this lower INR goal is safer while still protecting against dangerous clots.
This trial tests whether a personalized plan for blood thinners after TAVI can reduce the risk of stroke or bleeding better than the current standard of one daily blood thinner. If you've had a successful TAVI and don't need specific other blood thinners, you might be able to join.
Hear when a new Prosthetic Valve Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.